|
Volumn 23, Issue 19, 2005, Pages 4473-4474
|
Successful use of haploidentical stem-cell transplantation with KIR mismatch as initial therapy for poor-risk myelodysplastic syndrome [10]
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN;
CD34 ANTIGEN;
HEMOGLOBIN;
HLA A ANTIGEN;
HLA ANTIGEN;
ITRACONAZOLE;
MEMBRANE PROTEIN;
PROTEIN KIR;
RIBAVIRIN;
STEROID;
UNCLASSIFIED DRUG;
ADULT;
ASPERGILLUS FUMIGATUS;
BONE MARROW BIOPSY;
CASE REPORT;
CHROMOSOME ANALYSIS;
COLITIS;
COLON BIOPSY;
DIARRHEA;
DYSPLASIA;
GRAFT VERSUS HOST REACTION;
HAPLOIDY;
HUMAN;
KARYOTYPE;
LETTER;
MALE;
MISMATCH REPAIR;
MONOSOMY 7;
MYELODYSPLASTIC SYNDROME;
PANCYTOPENIA;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SEPSIS;
SIDEROBLASTIC ANEMIA;
SINUSITIS;
STEM CELL TRANSPLANTATION;
SURVIVAL;
T CELL DEPLETION;
TREATMENT DURATION;
HAPLOIDY;
HUMANS;
MYELODYSPLASTIC SYNDROMES;
STEM CELL TRANSPLANTATION;
|
EID: 22344450421
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.01.3581 Document Type: Letter |
Times cited : (15)
|
References (5)
|